GILD vs HNVR · P/E 18, rev $7.80B vs P/E 22, rev $64.4M
Gilead Sciences Inc (GILD) versus Hanover Bancorp Inc (HNVR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Hanover Bancorp Inc (HNVR) is a banks - regional company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported HNVR revenue for 2026-06-30 was $64.4M. Net income was $5.9M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. HNVR currently screens at market cap $168.9M and trailing P/E 22.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. HNVR currently screens at market cap $168.9M and trailing P/E 22.5.
Not investment advice. Open the GILD and HNVR stock pages for the full models.
Not investment advice.